Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Chest|May 22, 2021
A 27-Year-Old Man With Intermittent Chest Pain During the Last 4 YearsApostolos G Pappas, Konstantina Dede, Athina Kallimani, et al.Cancers|October 28, 2023
MTH1 Inhibition Alleviates Immune Suppression and Enhances the Efficacy of Anti-PD-L1 Immunotherapy in Experimental MesotheliomaSophia F Magkouta, Photene C Vaitsi, Marianthi P Iliopoulou, et al.JCI Insight|March 22, 2022
CSF1/CSF1R signaling mediates malignant pleural effusion formationChrysavgi N Kosti, Photene C Vaitsi, Apostolos G Pappas, et al.Journal of Personalized Medicine|September 23, 2022
Moderate COVID-19: Clinical Trajectories and Predictors of Progression and OutcomesApostolos G Pappas, Andreas Panagopoulos, Artemis Rodopoulou, et al.Oncoimmunology|February 5, 2019
Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growthApostolos G Pappas, Sophia Magkouta, Ioannis S Pateras, et al.Respirology Case Reports|November 17, 2021
Convalescent plasma therapy in an immunocompromised patient with multiple COVID-19 flares: a case reportFrini Karaolidou, Natasa-Eleni Loutsidi, Zois Mellios, et al.Viruses|January 8, 2025
Hypercoagulable Rotational Thromboelastometry During Hospital Stay Is Associated with Post-Discharge DLco Impairment in Patients with COVID-19-Related PneumoniaNatasa-Eleni Loutsidi, Marianna Politou, Vassilios Vlahakos, et al.JCI Insight|June 20, 2020
MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damageSophia F Magkouta, Apostolos G Pappas, Photene C Vaitsi, et al.Journal of Clinical Medicine|January 23, 2024
High Plasma Osteopontin Levels Are Associated with Serious Post-Acute-COVID-19-Related DyspneaApostolos G Pappas, Konstantinos Eleftheriou, Vassilios Vlahakos, et al.Pageof 1